ASH 66th Annual Meeting & Exposition: Friday Satellite Symposia


Bispecific Antibodies: A Playbook for Relapsed/Refractory Follicular Lymphoma

This program is supported by Genmab and AbbVie


3:00 p.m. - 6:00 p.m. Pacific time


ACCESS PROGRAM HERE


Marriott Marquis San Diego Marina
Marriott Grand Ballroom 11-13

On Demand program will be available here December 21, 2024.

Access Program Here


This live panel discussion will focus on the advancing field of bispecific antibodies in third-line relapsed/refractory follicular lymphoma. Experts in the field of follicular lymphoma, with the added perspective of a patient advocate, will review best practices for assessing and applying the latest data on bispecific antibodies, as well as strategies to enhance shared decision-making and patient-centered care.

Chair:

Joshua Brody, MD
Icahn School of Medicine at Mount Sinai
New York, NY

Speakers:

Krish Patel, MD
Director, Lymphoma Research, Sarah Cannon Research Institute
Nashville, TN

Lorna Warwick
Lymphoma Coalition
Mississauga, ON, CAN

Vikki Chavis , Medscape
Email: vchavis@medscapelive.com